Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1992010188) USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN THE TREATMENT OF HEMORRAGIC STROKE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1992/010188 International Application No.: PCT/GB1991/002226
Publication Date: 25.06.1992 International Filing Date: 12.12.1991
Chapter 2 Demand Filed: 28.05.1992
IPC:
A61K 31/41 (2006.01) ,A61K 31/415 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
415
1,2-Diazoles
Applicants:
SMITHKLINE BEECHAM PLC [GB/GB]; New Horizons Court Brentford Middlesex TW8 9EP, GB (AllExceptUS)
HILL, James [GB/GB]; GB (UsOnly)
Inventors:
HILL, James; GB
Agent:
THOMPSON, Clive, B.; Corporate Patents SmithKline Beecham Mundells, Welwyn Garden City Hertfordshire AL7 1EY, GB
Priority Data:
9027199.014.12.1990GB
Title (EN) USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN THE TREATMENT OF HEMORRAGIC STROKE
(FR) UTILISATION D'ANTAGONISTES DU RECEPTEUR DE L'ANGIOTENSINE II DANS LE TRAITEMENT D'ACCIDENTS HEMORRAGIQUES
Abstract:
(EN) The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of haemorrhagic stroke.
(FR) L'invention se rapporte à l'utilisation d'un antagoniste du récepteur de l'angiotensine II dans la fabrication d'un médicament servant à traiter les accidents hémorragiques.
Designated States: AU, CA, JP, KR, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, MC, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0561977US20010018448US20020086893US20030050285JPH06503558DE000069133390
AU1991090841